Breast Cancer Trial, Recruiting NCT07739121 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07739121
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • The case involves one of five specific cancer types: breast, lung, urological, digestive, or gynaecological.
  • The case includes all required details, such as the cancer stage (based on the UICC 8th edition system), relevant biomarker results, a measure of the patient's physical functioning (called ECOG performance status), existing health conditions, and a standardised clinical question.
  • The case includes a treatment-planning question that can be clearly answered using an established set of clinical guidelines (confirm with trial site).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The case involves a cancer type outside the five specified categories.
  • The case is missing required information, contains details that contradict each other, or is unclear in some way.
  • The case is the same as, or very similar to, another case already included in the trial.
  • The case includes a question that cannot be answered using current clinical guidelines.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01 56 09 34 06

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Domain-level performance between LLM recommendations and the locked guidelines.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov